Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
Conditions
Biliary Tract Cancer · HER2-positive Cancer · Advanced Cancer · Unresectable Biliary Tract Carcinoma · Metastatic Biliary Tract Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Homi Bhabha Cancer Hospital and Research Centre, Muzaffarpur, Muzaffarpur, Bihar, India
Tata Memorial Hospital, Mumbai, Maharashtra, India
PRABHAT BHARGAVA, DM (Sub-investigator)RITAM JOARDER, MD (Sub-investigator)MEHAK TRIKHA, MD (Sub-investigator)AKSHAY BAHETI, MD (Sub-investigator)RAJIV KAUSHAL, MD (Sub-investigator)SUBHASH YADAV, DNB (Sub-investigator)SHRADDHA PATKAR, Mch (Sub-investigator)MAHESH GOEL, MS (Sub-investigator)OMSHREE SHETTY, PhD (Sub-investigator)SUMAN ANKATHI, DNB (Sub-investigator)Institute of Medical Sciences & SUM Hospital, Bhubaneswar, Odisha, India
Homi Bhabha Cancer Hospital and Research Centre, Mūllānpur, Punjab, India
Contact: Principal Investigator (Pragyat Thakur)Mahamana Pandit Madan Mohan Malviya Cancer Centre (MPMMC) and Homi Bhabha Cancer Hospital (HBCH), Varanasi, Uttar Pradesh, India
MAX Super Speciality Hospital, SAKET, Delhi, India
Study leads
Vikas Ostwal, DM
Principal Investigator
Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India 400012